Research

The numerous research opportunities available at Mount Sinai are a cornerstone of the Hematology/Medical Oncology Fellowship Program. Icahn School of Medicine at Mount Sinai is ranked 13th among medical schools in National Institutes of Health (NIH) funding for 2023. Fellows have 18 months of protected, mentored research time during the latter half of their fellowship. By the end of the first year of fellowship, fellows identify an area of interest and a mentor and are guided through the process of developing a research project. Our expectation is that fellow research projects will result in presentations at national conferences and publications and will equip fellows to apply for mentored training grants and other funding to allow them to further develop their interests and foster careers as academic leaders and independent investigators. Fellows are able to choose from a broad range of faculty mentors focusing on a diverse array of research (including basic science, translational, clinical, outcomes, quality improvement, and medical education) within the Division of Hematology/Medical Oncology, Tisch Cancer Institute or other institutes within The Icahn School of Medicine at Mount Sinai. To further guide fellows and their faculty mentors, Fellow Research Guidelines have been developed and Research Advisory Committees formed to outline expectations between mentors and mentees, provide timelines for research plans, progress reports, presentations and publications. Opportunities for advanced training in clinical research through the Masters in Clinical Research (MSCR) or Masters in Public Health (MPH) through the Graduate School for Biomedical Science at the Icahn School of Medicine are also available.

Laboratory and Translational

View Investigators

Clinical Research

View Investigators

Outcomes, Quality Improvement, Population Health, Medical Education

View Investigators

Selected Publications

By our faculty (in bold) and fellows (in pink)

Waksal JA, Bruedigam C, Komrokji RS, Jamieson CHM, Mascarenhas JO. Blood Adv. 2023 Aug 22;7(16):4302-4314. doi: 10.1182/bloodadvances.2023009903. PMID: 37216228

Waksal JA, Harrison CN, Mascarenhas JO. Leuk Lymphoma. 2022 May;63(5):1020- 1033. doi: 10.1080/10428194.2021.2010068. Epub 2021 Dec 2. PMID: 34852713

Pan D, Richter J. Curr Hematol Malig Rep. 2024 Aug 15. doi: 10.1007/s11899-024- 00740-z. Online ahead of print. PMID: 39145912

Avigan ZM, Arinsburg S, Pan D, Mark T, Fausel C, Bubalo J, Milkovich G, Chari A, Richter J. Bone Marrow Transplant. 2024 Oct;59(10):1440-1448. doi: 10.1038/s41409- 024-02385-1. Epub 2024 Jul 31. PMID: 39085373

Pan D, Mouhieddine TH, Upadhyay R, Casasanta N, Lee A, Zubizarreta N, Moshier E, Richter J. Semin Oncol. 2023 Feb-Apr;50(1-2):40-48. doi: 10.1053/j.seminoncol.2023.03.006. Epub 2023 Mar 24. PMID: 37005144

Mouhieddine TH, Van Oekelen O, Melnekoff DT, Li J, Ghodke-Puranik Y, Lancman G, Thibaud S, Pan D, Rajeeve S, Agte S, Aleman A, Sanchez L, Richard S, Rossi A, Richter J, Cho HJ, Rodriguez C, Lagana A, Moshier E, Chari A, Jagannath S, Parekh S. Blood Adv. 2023 Mar 28;7(6):1056-1064. doi: 10.1182/bloodadvances.2022007923. PMID: 36018226

Nathan DI, Brander T, Gold J, Paul D, Klein P, Cheng K, Liu JM, Marcellino BK. JCO Precis Oncol. 2024 Jul;8: e2400006. doi: 10.1200/PO.24.00006. PMID: 38991177

Nathan DI, Dougherty M, Bhatta M, Mascarenhas J, Marcellino BK. Crit Rev Oncol Hematol. 2023 Dec;192:104187. doi: 10.1016/j.critrevonc.2023.104187. Epub 2023 Oct 23. PMID: 37879493

Handa S, Sivakumar G, Srisuwananukorn A, Dueck A, Tremblay D, Mascarenhas JO, Ginzburg Y, Kremyanskaya M, Hoffman R. Clin Lymphoma Myeloma Leuk. 2024 Sep;24(9):e314-e319. doi: 10.1016/j.clml.2024.05.012. Epub 2024 May 14. PMID: 38839448

Handa S, Lee JO, Derkach A, Stone RM, Saven A, Altman JK, Grever MR, Rai KR, Shukla M, Vemuri S, Montoya S, Taylor J, Abdel-Wahab O, Tallman MS, Park JH. Blood. 2022 Dec 22;140(25):2663-2671. doi: 10.1182/blood.2022016183. PMID: 35930750

Handa S, Sterpi M, Sacchi De Camargo Correia G, Frankel DS, Beilin Y, Cytryn L, Hawkins K, Frankel E. Blood Adv. 2023 May 23;7(10):1967-1975. doi: 10.1182/bloodadvances.2022008648. PMID: 36521104

Crowley F, Sterpi M, Buckley C, Margetich L, Handa S, Dovey Z. Res Rep Urol. 2021 Jun 30;13:457-472. doi: 10.2147/RRU.S264722. eCollection 2021. PMID: 34235102

Crowley F, Sheppard R, Lehrman S, Easton E, Marron TU, Doroshow D, Afezolli D. Cancer Treat Rev. 2024 Jul;128:102767. doi: 10.1016/j.ctrv.2024.102767. Epub 2024 May 19. PMID: 38776612

Miller EJ, Rose TL, Maughan BL, Milowsky MI, Bilen MA, Carthon BC, Gao X, Rapisuwon S, Zhao Q, Yu M, Agarwal N, Galsky MD. Cancer. 2024 May 1;130(9):1642- 1649. doi: 10.1002/cncr.35179. Epub 2024 Jan 5. PMID: 38180804

Miller EJ, Galsky MD. Curr Treat Options Oncol. 2023 Dec;24(12):1870-1888. doi: 10.1007/s11864-023-01151-7. Epub 2023 Dec 12. PMID: 38085403

Anker J, Pal SK, Kim-Schulze S, Wang H, Halperin R, Uzilov A, Imai N, Eikawa S, Saito T, Sebra R, Hahn NM, Patel M, Qi J, Xie H, Bhardwaj N, Gnjatic S, Galsky MD. J Immunother Cancer. 2023 Aug;11(8):e007613. doi: 10.1136/jitc-2023-007613. PMID: 37607770

Hemenway G, Anker JF, Riviere P, Rose BS, Galsky MD, Ghatalia P. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e432054. doi: 10.1200/EDBK_432054. PMID: 38771987

Guitart X, Porubsky D, Yoo D, Dougherty ML, Dishuck P, Munson KM, Lewis AP, Hoekzema K, Knuth J, Chang S, Pastinen T, Eichler EE. Genome Res. 2024 Aug 6:gr.279299.124. doi: 10.1101/gr.279299.124. Online ahead of print. PMID: 39107043

Metzger M, Mascarenhas J. Expert Opin Pharmacother. 2024 Aug;25(12):1585-1590. doi: 10.1080/14656566.2024.2396029. Epub 2024 Aug 26. PMID: 39169882

Rippel N, Tremblay D, Zubizarreta N, Podoltsev N, Gotlib J, Heaney M, Kuykendall A, O'Connell C, Shammo JM, Fleischman A, Kremyanskaya M, Hoffman R, Mesa R, Yacoub A, Mascarenhas J. Leuk Res. 2022 Aug;119:106903. doi: 10.1016/j.leukres.2022.106903. Epub 2022 Jun 16.

Tremblay D, Rippel N, Feld J, El Jamal SM, Mascarenhas J. Oncologist. 2021 May;26(5):406-421. doi: 10.1002/onco.13769. Epub 2021 Apr 21. PMID: 33792103

Avigan ZM, Joshua Richter Md. Oncology (Williston Park). 2024 Jun 10;38(6):239-241. doi: 10.46883/2024.25921023. PMID: 38899981

Fruchtman H, Avigan ZM, Waksal JA, Brennan N, Mascarenhas JO. Leukemia. 2024 May;38(5):927-935. doi: 10.1038/s41375-024-02246-2. Epub 2024 Apr 10. PMID: 38600315

Liu A, Rupani KV, Naymagon L. Eur J Haematol. 2022 Jul;109(1):69-74. doi: 10.1111/ejh.13770. Epub 2022 Apr 5. PMID: 35305281

Crowley F, Brown S, Gallagher EJ, Dayan JH. Front Oncol. 2024 Apr 18;14:1392375. doi: 10.3389/fonc.2024.1392375. eCollection 2024. PMID: 38699640

Crowley F, Gandhi S, Rudshteyn M, Sehmbhi M, Cohen DJ. Oncologist. 2023 Jun 2;28(6):486-493. doi: 10.1093/oncolo/oyad044. PMID: 36933202

Crowley F, Mihalopoulos M, Gaglani S, Tewari AK, Tsao CK, Djordjevic M, Kyprianou N, Purohit RS, Lundon DJ. Br J Cancer. 2023 Jan;128(2):177-189. doi: 10.1038/s41416-022-01989-y. Epub 2022 Oct 19. PMID: 36261584

Contact Us

Autumn Wert

Administrative Manager Division of Hematology & Medical Oncology

Autumn.wert@mssm.edu

Icahn School of Medicine at Mount Sinai One Gustave L. Levy Place Box 1079 New York, NY 10029 (212) 241-4705

View:

Coronavirus Response